Sarepta names Michael Severino CEO, succeeding retiring Doug Ingram

PUBT · 3d ago
Sarepta names Michael Severino CEO, succeeding retiring Doug Ingram
  • Sarepta appointed Michael Severino as CEO, effective July 28, 2026.
  • Severino was previously CEO of Tessera Therapeutics.
  • He earlier served as vice chairman, president at AbbVie, leading R&D, corporate strategy.
  • Severino will join the board; Doug Ingram will retire, remain an adviser through end-2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sarepta Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260727284554) on July 27, 2026, and is solely responsible for the information contained therein.